LU90118B1 - Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues - Google Patents

Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues Download PDF

Info

Publication number
LU90118B1
LU90118B1 LU90118A LU90118A LU90118B1 LU 90118 B1 LU90118 B1 LU 90118B1 LU 90118 A LU90118 A LU 90118A LU 90118 A LU90118 A LU 90118A LU 90118 B1 LU90118 B1 LU 90118B1
Authority
LU
Luxembourg
Prior art keywords
melatonin
addiction
patients
treatment
certain drugs
Prior art date
Application number
LU90118A
Other languages
English (en)
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Application granted granted Critical
Publication of LU90118B1 publication Critical patent/LU90118B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
LU90118A 1995-02-01 1997-08-01 Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues LU90118B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (fr) 1995-02-01 1995-06-06 Utilisation de la mélatonine pour traiter les patients souffrant d'une dépendance vis à vis d'une drogue
PCT/IB1996/000082 WO1996023496A1 (fr) 1995-02-01 1996-01-29 Utilisation de la melatonine dans le traitement des patients souffrant d'accoutumance a certaines drogues

Publications (1)

Publication Number Publication Date
LU90118B1 true LU90118B1 (fr) 1997-11-13

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90118A LU90118B1 (fr) 1995-02-01 1997-08-01 Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues

Country Status (22)

Country Link
JP (1) JP4516159B2 (fr)
CN (1) CN1083263C (fr)
AT (1) AT408188B (fr)
AU (1) AU695366B2 (fr)
BG (1) BG62876B1 (fr)
BR (1) BR9607169A (fr)
CZ (1) CZ291349B6 (fr)
DK (1) DK176081B1 (fr)
EE (1) EE03384B1 (fr)
FI (1) FI119586B (fr)
IS (1) IS1980B (fr)
LU (1) LU90118B1 (fr)
LV (1) LV11940B (fr)
MD (1) MD1716C2 (fr)
NO (1) NO312814B1 (fr)
NZ (1) NZ298878A (fr)
PL (1) PL183148B1 (fr)
SI (1) SI9620022A (fr)
SK (1) SK284521B6 (fr)
TR (1) TR199700723T1 (fr)
TW (1) TW483757B (fr)
WO (1) WO1996023496A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1272177E (pt) 2000-01-05 2007-07-11 Neurim Pharma 1991 Método e formulação para o tratamento da resistência aos antihipertensos e condições associadas.
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
AU2013211880A1 (en) * 2012-01-26 2014-08-21 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
EP3767297A1 (fr) 2012-12-18 2021-01-20 Vanda Pharmaceuticals Inc. Traitement des troubles du rythme circadien
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
EP3777842A1 (fr) * 2016-10-31 2021-02-17 Neurim Pharmaceuticals Ltd. Mini-comprimés de mélatonine et leur procédé de fabrication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE181670T1 (de) * 1991-05-09 1999-07-15 Neurim Pharma 1991 Melatonin enthaltende arzneimittel
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
TW483757B (en) 2002-04-21
ATA901396A (de) 2001-02-15
AU4457496A (en) 1996-08-21
JP4516159B2 (ja) 2010-08-04
FI119586B (fi) 2009-01-15
MD1716B2 (en) 2001-08-31
IS1980B (is) 2005-01-14
PL321630A1 (en) 1997-12-08
LV11940B (en) 1998-05-20
IS4532A (is) 1997-07-25
DK176081B1 (da) 2006-04-18
CZ240597A3 (cs) 1998-01-14
CN1083263C (zh) 2002-04-24
AU695366B2 (en) 1998-08-13
TR199700723T1 (xx) 1998-02-21
MX9705856A (es) 1998-07-31
SK103097A3 (en) 1998-01-14
EE9700166A (et) 1998-02-16
DK89697A (da) 1997-07-30
EE03384B1 (et) 2001-04-16
CN1172431A (zh) 1998-02-04
FI973185A (fi) 1997-09-30
MD970254A (en) 1999-05-31
WO1996023496A1 (fr) 1996-08-08
BG62876B1 (bg) 2000-10-31
JPH10513177A (ja) 1998-12-15
FI973185A0 (fi) 1997-07-31
NO312814B1 (no) 2002-07-08
NO973531L (no) 1997-09-30
LV11940A (lv) 1998-01-20
MD1716C2 (ro) 2002-02-28
BR9607169A (pt) 1997-11-11
PL183148B1 (pl) 2002-05-31
AT408188B (de) 2001-09-25
NZ298878A (en) 1999-05-28
SI9620022A (sl) 1998-10-31
NO973531D0 (no) 1997-07-31
BG101803A (en) 1998-04-30
SK284521B6 (sk) 2005-05-05
CZ291349B6 (cs) 2003-02-12

Similar Documents

Publication Publication Date Title
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
IT9083334A0 (it) Procedimento per l'estrazione e la purificazione di dna genomico umano
DE69332952D1 (de) Diagnostische und therapeutische Einheiten enthaltende biokompatible Polymere
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
DE69635364D1 (de) Blutfilter und extrakorporaler Kreislauf
HUP0104803A3 (en) Process and system for the administration of medicine through the skin
LU90118B1 (fr) Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues
HK1001375A1 (en) Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
FR2717080B1 (fr) Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
FI941345A0 (fi) Retinoidit ja niiden käyttö ihosairauksien ja leukemian hoitoon
KR960702315A (ko) 혈관 차단 치료에서의 헤모글로빈의 치료적 용도 (Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage)
FR2684552B1 (fr) Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants.
FR2792199B3 (fr) Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
FR2759906B1 (fr) Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques
FR2774596B1 (fr) Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer
ZA9610584B (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
FR2722989B1 (fr) Utilisation de l'ifenprodil et de ses enantiomeres pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques et des maladies neurodegeneratives centrales
FR2744364B1 (fr) Application d'ureidoacetamides a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
GB2284153B (en) Substances for use in treatment of HIV-infection in HIV-infected patients
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances
FR2702151B1 (fr) Application d'anticonvulsivants dans le traitement du neuro-sida.
GB9701919D0 (en) Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1
FR2758980B1 (fr) Appareil d'hydrotherapie de traitement local et general du corps
FR2744363B1 (fr) Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri